Fair Value Calculator Fair Value Calculator
EN DE

Englewood Lab, Inc (950140) Fair Value & Analysis

Consumer Defensive · KR · Market cap 183B KRW

EL Englewood Lab, Inc 950140 · KQ
Price8,800 KRW
Fair Value26,229 KRW
Upside+198.1%
Quality51/100
Watch Englewood Lab, Inc for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range 19,671 KRW – 44,311 KRW

Fair value as of: Jul 12, 2026

From 24 valuation models · updated today

Share price −1.0% over the past month.

Price vs Fair Value (12 months)

15,730 KRW 7,930 KRW Fair Value 26,229 KRW Jun 2025 Jul 2026

12‑month range 7,930 KRW – 15,730 KRW · fair‑value band 19,671 KRW – 44,311 KRW · the 8,800 KRW price screens below the 26,229 KRW fair value. As of Jul 12, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Englewood Lab, Inc (950140) currently trades at 8,800 KRW, while our model-based Fair Value estimate is 26,229 KRW — implying the stock looks roughly 198.1% undervalued today. We read business quality at 51/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, Englewood Lab, Inc generated revenue of 224B KRW at a net margin of 12.8%. Revenue grew 16.9% year over year. It earns a return on equity of 18.1%. Net debt stands at 11.5B KRW. Fundamentals as of Jul 12, 2026

Our scenario range runs from 19,671 KRW (bear case) to 44,311 KRW (bull case); at 8,800 KRW, the current price sits below that range. The share trades about 48% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -50% fair-value upside — at 198%, 950140 screens cheaper than that median.

Key figures & financial health

Revenue (TTM) 224B KRW
Revenue growth (YoY) +16.9%
Net margin 12.8%
Return on equity 18.1%
Free cash flow 15.7B KRW FY2025
Operating margin 11.3%
More key figures
Dividend yield 2.2%
EPS growth (YoY) +120%
Net debt 11.5B KRW FY2022

Figures from reported company fundamentals (EODHD) · as of Jul 12, 2026. TTM = trailing twelve months.

About the company

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; and over the counter products, such as SPF/ACNE, personal hygiene, and skin protectant. The company was founded in 2004 and is headquartered in Totowa, New Jersey. Englewood Lab, Inc. is a subsidiary of Cosmecca Korea Co., Ltd.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Englewood Lab, Inc reported revenue of 217B KRW in FY2025 versus 141M KRW in FY2021, a compound +526.7%/yr. Reported net income was 24.8B KRW in FY2025, compounding +559.7%/yr from FY2021.

Revenue +526.7%/yr
FY21 141M KRW
FY22 117M KRW
FY23 158M KRW
FY24 134M KRW
FY25 217B KRW
Net income +559.7%/yr
FY21 13.1M KRW
FY22 5.6M KRW
FY23 15.9M KRW
FY24 14.4M KRW
FY25 24.8B KRW

Is 950140 fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Englewood Lab, Inc Fair Value". https://www.fairvalue-calculator.com/stock/950140

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG 2,590 MXN 108.66 MXN -96%
L'Oréal S.A LRLCF $428.02 $273.79 -36%
Unilever PLC UNLYF $59.34 $46.11 -22%
Colgate-Palmolive Company CL $85.10 $41.68 -51%
Hindustan Unilever Limited HINDUNILVR ₹2,122 ₹677.55 -68%
Reckitt Benckiser Group RBGLY $12.32 $17.37 +41%
Kimberly-Clark Corporation KMBB34 R$530.90 R$72.97 -86%
Church & Dwight Co CHDC34 R$488.56 R$243.53 -50%
Essity AB ESSITYB kr 270.40 kr 276.64 +2%
Godrej Consumer Products Limited GODREJCP ₹1,020 ₹382.03 -63%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Englewood Lab, Inc (950140) undervalued?
As of Jul 12, 2026, our model estimates a fair value of 26,229 KRW versus a price of 8,800 KRW — about +198% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 950140?
Our model-based fair value for Englewood Lab, Inc is 26,229 KRW (as of Jul 12, 2026), built from audited fundamentals. The current price is 8,800 KRW.
What is the quality score of 950140?
Englewood Lab, Inc has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Englewood Lab, Inc (950140)?
Englewood Lab, Inc reported trailing-twelve-month revenue of about 224B KRW (latest available figure, as of Jul 12, 2026).
What is the net profit margin of 950140?
The net profit margin of Englewood Lab, Inc is about 12.8%, meaning it keeps roughly 12.8% of revenue as net income. Based on the latest reported figures.
Does Englewood Lab, Inc pay a dividend?
Englewood Lab, Inc currently shows a dividend yield of about 2.19% relative to its recent price (as of Jul 12, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

14 days Pro free · no card

Unlock the full Englewood Lab, Inc analysis — and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.